We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Corporate Advert

Home > News > Testing

Oklahoma Cannabis Testing Lab Under State Investigation

Aug 26, 2020

Oklahoma Cannabis Testing Lab Under State Investigation

State authorities have begun an investigation into a cannabis testing lab over allegations of falsified testing results, according to the local newspaper the Tulsa World.

This Monday, August 25, a spokesperson from the Oklahoma Medical Marijuana Authority (OMMA) confirmed to the newspaper that F.A.S.T. Laboratories, a testing facility based in Oklahoma City, “has pending inquiries with the OMMA and the Oklahoma Bureau of Narcotics and Dangerous Drugs.”

In response, F.A.S.T. Labs’ owner Kyle Felling told the Tulsa World that he was “aware of a complaint” and that he was cooperating fully with state regulators.


Testing in Oklahoma

Oklahoma began requiring medical cannabis testing last month. From July 1, all marijuana products sold by a grower or processor to a medical dispensary must have first been tested by a lab authorized by the OMMA. There are now 23 such licensed cannabis testing labs in the state, including F.A.S.T. Laboratories, according to the OMMA website.

All lab tests should result in a certificate of analysis, say the OMMA, which detail the products’ levels of THC, CBD, terpenes, and microbial and heavy metal contaminants.

The new testing rule was initially meant to take effect on April 1, but delays were made amid the coronavirus pandemic.

Oklahoma’s medical cannabis program launched in October 2018, and currently generates nearly $10 million a month in state tax revenue, according to the state’s Tax Commission.

 

Like what you just read? You can find similar content on the topic tags shown below.

Policy Testing

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

Comments
Advertisement